Catch pre-market movers with AI signals.
ZYXI(Quitar la ciudad)
Zynex (ZYXI) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Zynex market cap is -- and enterprise value is --.
Share Statistics
Zynex has 30.30M shares outstanding, with a free float of 15.82M.
Valuation Ratios
Zynex's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Zynex debt-to-equity ratio is -1.43 and debt-to-assets ratio is 1.91.
Liquidity
Zynex's current ratio is 0.47, quick ratio is 0.32, and cash ratio is 0.17, showing its short-term liquidity position.
Return on Capital
Zynex's ROE is --, ROA is -86.31%, and ROIC is -126.57%, showing its return on capital profile.
Profitability
Zynex gross margin is 71.64%, operating margin is -62.76%, and net margin is -68.35%.
Operating Efficiency
Zynex's asset turnover is 1.26, inventory turnover is 2.22, and receivables turnover is 7.64, indicating its operating efficiency.
Income Statement
Zynex's revenue is 144.81M, gross profit is 77.51M, net income is -28.66M, and EBITDA is -15.49M.
Balance Sheet
Zynex's total debt is 59.33M, net debt is 46.08M, total equity is -41.37M, and cash is 13.26M.
Cash Flow Statement
Zynex's operating cash flow is -7.18M, free cash flow is -7.67M, and CapEx is -485.00K.
Dividends & Yields
Zynex dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Zynex's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
An innovative medical technology company that specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring
Per Share Metrics
Zynex's EPS is -2.41, book value per share is -1.36, and free cash flow per share is --.
